Krystal Biotech, Inc. KRYS Lease liability
Lease liability at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:IncreaseDecreaseInLeaseLiability.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s lease liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s lease liability?
- Krystal Biotech, Inc. (KRYS) reported lease liability of -$227K in Q1 2026.
- How has Krystal Biotech, Inc.'s lease liability changed year-over-year?
- Krystal Biotech, Inc.'s lease liability decreased by 66.9% year-over-year, from -$136K to -$227K.
- What is the long-term trend for Krystal Biotech, Inc.'s lease liability?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s lease liability has grown at a 19.3% compound annual growth rate (CAGR), from -$285K to -$578K.
- What does lease liability mean?
- The change in the company's obligation to make future lease payments.
- How do you interpret lease liability?
- An increase suggests the acquisition of new leased assets, while a decrease reflects the repayment of lease obligations over time.
- How does lease liability compare across companies?
- Standardized under modern accounting rules (ASC 842/IFRS 16) for all companies with significant real estate or equipment leases.